SPOREGEN LTD has a total of 17 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2017. It filed its patents most often in United Kingdom, China and EPO (European Patent Office). Its main competitors in its focus markets foods and drinks, pharmaceuticals and biotechnology are GUANGZHOU SAILAI STEMCELL SCIENCE AND TECHNOLOGY CO LTD, AHN DONG HYUN and INNER MONGOLIA SHUANGQI PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 5 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Republic of Korea | 2 | |
#5 | United States | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Australia | 1 | |
#8 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Foods and drinks | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Special foods | |
#4 | Foods | |
#5 | Microorganisms | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Cutting Simon | 12 |
#2 | Huynh Hong | 7 |
Publication | Filing date | Title |
---|---|---|
GB202013874D0 | Treatment and prevention of viral infections | |
GB201911925D0 | Formulations for prevention or reduction of c. difficile infections | |
GB201802720D0 | Pathogenic bacteria | |
GB201718133D0 | Modified bacterial spores | |
GB201712904D0 | Vaccine |